Legal & General Group’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.04M | Buy |
211,967
+2,204
| +1% | +$48K | ﹤0.01% | 1485 |
|
|
2026
Q1 | $3.64M | Sell |
209,763
-20,719
| -9% | -$392K | ﹤0.01% | 1661 |
|
|
2025
Q4 | $4.34M | Buy |
230,482
+70,480
| +44% | +$1.18M | ﹤0.01% | 1634 |
|
|
2025
Q3 | $2.33M | Buy |
160,002
+42,476
| +36% | +$606K | ﹤0.01% | 1918 |
|
|
2025
Q2 | $2.3M | Buy |
117,526
+20,317
| +21% | +$361K | ﹤0.01% | 1916 |
|
|
2025
Q1 | $1.73M | Buy |
97,209
+7,458
| +8% | +$161K | ﹤0.01% | 1984 |
|
|
2024
Q4 | $1.92M | Buy |
89,751
+6,201
| +7% | +$151K | ﹤0.01% | 1991 |
|
|
2024
Q3 | $2.61M | Buy |
83,550
+13,408
| +19% | +$334K | ﹤0.01% | 1867 |
|
|
2024
Q2 | $1.09M | Sell |
70,142
-19,115
| -21% | -$231K | ﹤0.01% | 2165 |
|
|
2024
Q1 | $945K | Sell |
89,257
-37,465
| -30% | -$375K | ﹤0.01% | 2214 |
|
|
2023
Q4 | $1.52M | Sell |
126,722
-109,817
| -46% | -$900K | ﹤0.01% | 2070 |
|
|
2023
Q3 | $1.66M | Sell |
236,539
-44,814
| -16% | -$414K | ﹤0.01% | 1979 |
|
|
2023
Q2 | $2.39M | Buy |
281,353
+234,574
| +501% | +$1.96M | ﹤0.01% | 1840 |
|
|
2023
Q1 | $428K | Sell |
46,779
-136,987
| -75% | -$1.75M | ﹤0.01% | 2360 |
|
|
2022
Q4 | $2.1M | Buy |
183,766
+38,149
| +26% | +$565K | ﹤0.01% | 1864 |
|
|
2022
Q3 | $2.48M | Buy |
145,617
+28,855
| +25% | +$619K | ﹤0.01% | 1755 |
|
|
2022
Q2 | $2.51M | Buy |
116,762
+13,507
| +13% | +$375K | ﹤0.01% | 1774 |
|
|
2022
Q1 | $3.82M | Sell |
103,255
-1,212
| -1% | -$47.2K | ﹤0.01% | 1673 |
|
|
2021
Q4 | $4.75M | Buy |
104,467
+20,742
| +25% | +$1.08M | ﹤0.01% | 1592 |
|
|
2021
Q3 | $5.3M | Buy |
83,725
+16,697
| +25% | +$1.27M | ﹤0.01% | 1519 |
|
|
2021
Q2 | $6.13M | Sell |
67,028
-9,174
| -12% | -$729K | ﹤0.01% | 1440 |
|
|
2021
Q1 | $5.19M | Buy |
76,202
+46,533
| +157% | +$3.61M | ﹤0.01% | 1538 |
|
|
2020
Q4 | $2.15M | Buy |
29,669
+528
| +2% | +$30.6K | ﹤0.01% | 1860 |
|
|
2020
Q3 | $1.1M | Buy |
29,141
+20,115
| +223% | +$679K | ﹤0.01% | 1995 |
|
|
2020
Q2 | $320K | Buy |
9,026
+1,217
| +16% | +$34.6K | ﹤0.01% | 2265 |
|
|
2020
Q1 | $171K | Sell |
7,809
-1,810
| -19% | -$40.6K | ﹤0.01% | 2308 |
|
|
2019
Q4 | $207K | Buy |
9,619
+1,538
| +19% | +$35.3K | ﹤0.01% | 2391 |
|
|
2019
Q3 | $183K | Hold |
8,081
| – | – | ﹤0.01% | 2366 |
|
|
2019
Q2 | $291K | Buy |
8,081
+1,231
| +18% | +$39.4K | ﹤0.01% | 2252 |
|
|
2019
Q1 | $216K | Buy |
6,850
+721
| +12% | +$21K | ﹤0.01% | 2318 |
|
|
2018
Q4 | $154K | Buy |
6,129
+998
| +19% | +$25.6K | ﹤0.01% | 2360 |
|
|
2018
Q3 | $148K | Buy |
5,131
+309
| +6% | +$5.78K | ﹤0.01% | 2397 |
|
|
2018
Q2 | $59K | Buy |
+4,822
| New | +$55.3K | ﹤0.01% | 2674 |
|
Other funds holding CDNA
DM
AIM
GS
Legal & General Group's CDNA Position: Q2 2026 in Review
Legal & General Group increased its CareDx (CDNA) stake by 1.1% in Q2 2026, buying an estimated $48K and bringing the position to 211,967 shares worth $6.04M. The position accounts for ﹤0.01% of the portfolio, ranked #1485.
Legal & General Group first reported a position in CDNA in Q2 2018 and has held it in 33 quarters since. The position peaked at $6.13M in Q2 2021. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.
- Legal & General Group held 211,967 shares of CareDx worth $6.04M as of Q2 2026.
- Legal & General Group bought 2,204 CareDx shares in Q2 2026, an estimated $48K.
- CareDx made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #1485 holding.
- Legal & General Group first reported a position in CareDx in Q2 2018 and has held it in 33 quarters since.
- Legal & General Group's CareDx position peaked at $6.13M in Q2 2021.
- 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.
Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.